Search Results - "Wei, John X."
-
1
Impact of race and ethnicity on early mortality in multiple myeloma: a SEER analysis
Published in Haematologica (Roma) (01-05-2024)“…Over the past two decades, there have been significant advances in the treatment of multiple myeloma which has led to an improvement in overall survival.1,2…”
Get full text
Journal Article -
2
Bcl-2 inhibition in the treatment of hematologic malignancies
Published in Frontiers in hematology (04-12-2023)“…Apoptosis is a tightly regulated process of cell death occurring through extrinsic and intrinsic pathways. The Bcl-2 family of proteins is implicated in the…”
Get full text
Journal Article -
3
Socio-demographic determinants of myelofibrosis outcomes in an underserved center and the SEER national database
Published in Annals of hematology (01-09-2024)“…The influence of demographic characteristics and social determinants on cancer outcomes is widely recognized in various malignancies but remains understudied…”
Get full text
Journal Article -
4
Adjuvant therapy in localized vs regional biliary tract cancers: A SEER analysis
Published in Journal of clinical oncology (01-06-2023)“…e16221 Background: Biliary Tract Cancers (BTC) are aggressive malignancies. Treatment of early-stage disease involves surgical resection, but whether adjuvant…”
Get full text
Journal Article -
5
Predictive factors for academic oncology career placement
Published in Journal of clinical oncology (01-06-2024)“…9039 Background: Oncology is a discipline that has witnessed rapid expansion with new therapeutics and practices. Following this trend, training programs are…”
Get full text
Journal Article -
6
Assessing Epidemiological Differences in Myelofibrosis: A Comparative Study of a Single-Center Cohort and the SEER National Database
Published in Blood (02-11-2023)“…Background Myelofibrosis (MF) is a rare class of BCR-ABL negative myeloproliferative neoplasms characterized by clonal proliferation of hematopoietic stem…”
Get full text
Journal Article -
7
Access to care in patients with pancreatic adenocarcinoma by race/ethnicity in an academic center in the Bronx, NY
Published in Journal of clinical oncology (01-06-2022)“…e16280 Background: Racial disparities in the overall survival (OS) of patients with pancreatic adenocarcinoma (PDAC) have been previously reported. Large…”
Get full text
Journal Article -
8
Real-world analysis of the impact of race on immunotherapy in non-small cell lung cancers
Published in Journal of clinical oncology (01-06-2022)“…e18692 Background: Immunotherapy (IO) has become an essential component in the treatment of NSCLC. However, there is limited data on the clinical impact of IO…”
Get full text
Journal Article -
9
Clinical efficacy of frontline immunotherapy (IO) in ethnic-minority patients (pts) with metastatic NSCLC
Published in Journal of clinical oncology (01-06-2023)“…e21063 Background: Since minority pts have been historically underrepresented in key IO trials, knowledge on the clinical use of IO in ethnic-minority pts with…”
Get full text
Journal Article -
10
A Single Center Analysis of Hematopoietic Recovery in Patients Undergoing Allogeneic BMT with Suboptimal CD34+ Doses
Published in Blood (15-11-2022)Get full text
Journal Article -
11
Factors Associated with Early Mortality in Patients with Multiple Myeloma: A SEER Analysis
Published in Blood (15-11-2022)Get full text
Journal Article